If the decrease in SIRT2 activity in the pancreas accelerates the accumulation of oncogenic Kras mutations, it seems reasonable to propose that caerulein-induced pancreatitis in Sirt2−/− mice would be a useful model system for spontaneous Kras mutation-initiated pancreatic cancer in humans. The gene discussed is SIRT2; the disease is pancreatic neoplasm.